EOM Pharmaceuticals Holdings, Inc.
IMUC
$0.1388
-$0.0099-6.66%
OTC PK
| 09/30/2022 | 03/31/2022 | 12/31/2021 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 349.40K | 412.40K | 73.50K | 73.50K | 181.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 681.90K | 795.60K | 418.10K | 418.10K | 496.40K |
| Operating Income | -681.90K | -795.60K | -418.10K | -418.10K | -496.40K |
| Income Before Tax | -763.00K | -785.30K | -2.95M | -2.95M | -501.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -763.00K | -785.30K | -2.95M | -2.95M | -501.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -763.00K | -785.30K | -2.95M | -2.95M | -501.90K |
| EBIT | -681.90K | -795.60K | -418.10K | -418.10K | -496.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.01 | -0.07 | -0.07 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.08 | -0.08 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 113.27M | 113.27M | 40.14M | 40.14M | 45.08M |
| Average Diluted Shares Outstanding | 113.27M | 113.27M | 40.14M | 40.14M | 45.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |